Approvals/TGA/FOSAPREPITANT-AFT fosaprepitant (as dimeglumine) 150 mg powder for injection vial

Approved

STANDARD

FOSAPREPITANT-AFT fosaprepitant (as dimeglumine) 150 mg powder for injection vial

AFT Pharmaceuticals Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 3a33b4ef07b9db90
Product Name: FOSAPREPITANT-AFT fosaprepitant (as dimeglumine) 150 mg powder for injection vial
Artg Id: 378090
Artg Name: FOSAPREPITANT-AFT fosaprepitant (as dimeglumine) 150 mg powder for injection vial
Sponsor: AFT Pharmaceuticals Pty Ltd
Company Detail Path: /organization/aft-pharmaceuticals-au-pty-ltd
Artg Date: 2022-10-04
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/968b4bce63bcc1980fda29b80643c9c3.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/5545b3806ddffff7e40d9ba024230a32.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 29, 2025

Approval ID

3a33b4ef07b9db90

Type

Standard